Increased platelet activation in patients with stable and acute exacerbation of COPD.


Abstract

Patients with stable COPD have increased circulating platelet-monocyte aggregates compared with well-matched controls.

Platelet activation is further increased in patients with COPD during an acute exacerbation.

These findings identify a novel mechanism to explain the increased cardiovascular risk in COPD and suggest platelet inhibition as a plausible therapeutic target.


Full Text


Temas


Artículos similares

Español | English

© Galenicom 1999-2013